EMA/CO regimen (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine)

Type: drug

Status: Standard of Care

Developer: N/A (protocol)

Breakthrough Summary

No summary available.

Mechanism of Action

Details pending.

Year: 2026